FDA to Hold Public Workshop to Discuss Biosimilar Product Development September 1, 2022 Leave a Comment The US Food and Drug Administration is hosting a one-day virtual public workshop called “Increasing the Efficiency of Biosimilar Development Programs” on September 19 from 9 a.m. to 4 p.m.